These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 30880248)
21. The thioredoxin system and cancer therapy: a review. Mohammadi F; Soltani A; Ghahremanloo A; Javid H; Hashemy SI Cancer Chemother Pharmacol; 2019 Nov; 84(5):925-935. PubMed ID: 31367788 [TBL] [Abstract][Full Text] [Related]
22. B5, a thioredoxin reductase inhibitor, induces apoptosis in human cervical cancer cells by suppressing the thioredoxin system, disrupting mitochondrion-dependent pathways and triggering autophagy. Shao FY; Du ZY; Ma DL; Chen WB; Fu WY; Ruan BB; Rui W; Zhang JX; Wang S; Wong NS; Xiao H; Li MM; Liu X; Liu QY; Zhou XD; Yan HZ; Wang YF; Chen CY; Liu Z; Chen HY Oncotarget; 2015 Oct; 6(31):30939-56. PubMed ID: 26439985 [TBL] [Abstract][Full Text] [Related]
23. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol. Huang J; Xu J; Tian L; Zhong L Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200 [TBL] [Abstract][Full Text] [Related]
24. 6-Shogaol as a Novel Thioredoxin Reductase Inhibitor Induces Oxidative-Stress-Mediated Apoptosis in HeLa Cells. Peng S; Yu S; Zhang J; Zhang J Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902397 [TBL] [Abstract][Full Text] [Related]
25. Peperomin E and its orally bioavailable analog induce oxidative stress-mediated apoptosis of acute myeloid leukemia progenitor cells by targeting thioredoxin reductase. Wang X; Gao M; Zhang J; Ma Y; Qu W; Liang J; Wu H; Wen H Redox Biol; 2019 Jun; 24():101153. PubMed ID: 30909158 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767 [TBL] [Abstract][Full Text] [Related]
28. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Lu J; Chew EH; Holmgren A Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12288-93. PubMed ID: 17640917 [TBL] [Abstract][Full Text] [Related]
29. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452 [TBL] [Abstract][Full Text] [Related]
30. Targeting thioredoxin reductase by plumbagin contributes to inducing apoptosis of HL-60 cells. Zhang J; Peng S; Li X; Liu R; Han X; Fang J Arch Biochem Biophys; 2017 Apr; 619():16-26. PubMed ID: 28249720 [TBL] [Abstract][Full Text] [Related]
31. 2a, a novel curcumin analog, sensitizes cisplatin-resistant A549 cells to cisplatin by inhibiting thioredoxin reductase concomitant oxidative stress damage. Zhou B; Huang J; Zuo Y; Li B; Guo Q; Cui B; Shao W; Du J; Bu X Eur J Pharmacol; 2013 May; 707(1-3):130-9. PubMed ID: 23524096 [TBL] [Abstract][Full Text] [Related]
32. Daucosterol disturbs redox homeostasis and elicits oxidative-stress mediated apoptosis in A549 cells via targeting thioredoxin reductase by a p53 dependent mechanism. Rajavel T; Banu Priya G; Suryanarayanan V; Singh SK; Pandima Devi K Eur J Pharmacol; 2019 Jul; 855():112-123. PubMed ID: 31059712 [TBL] [Abstract][Full Text] [Related]
33. Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents. Liu Y; Li Y; Yu S; Zhao G Curr Drug Targets; 2012 Oct; 13(11):1432-44. PubMed ID: 22876886 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of Piperine analogs as thioredoxin reductase inhibitors to cause oxidative stress-induced cancer cell apoptosis. Zhong M; Chen L; Tao Y; Zhao J; Chang B; Zhang F; Tu J; Cai W; Zhang B Bioorg Chem; 2023 Sep; 138():106589. PubMed ID: 37320912 [TBL] [Abstract][Full Text] [Related]
35. Susceptibility of the antioxidant selenoenyzmes thioredoxin reductase and glutathione peroxidase to alkylation-mediated inhibition by anticancer acylfulvenes. Liu X; Pietsch KE; Sturla SJ Chem Res Toxicol; 2011 May; 24(5):726-36. PubMed ID: 21443269 [TBL] [Abstract][Full Text] [Related]
36. The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase. Tibodeau JD; Benson LM; Isham CR; Owen WG; Bible KC Antioxid Redox Signal; 2009 May; 11(5):1097-106. PubMed ID: 18999987 [TBL] [Abstract][Full Text] [Related]
37. Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic. Ren X; Zou L; Lu J; Holmgren A Free Radic Biol Med; 2018 Nov; 127():238-247. PubMed ID: 29807162 [TBL] [Abstract][Full Text] [Related]